STOCK TITAN
  1. Home
  2. PAND

Pandion Therapeutics (PAND) Stock Price, News & Analysis

PAND NASDAQ

Company Description

Pandion Therapeutics (NASDAQ: PAND) is classified in the research and development in biotechnology industry within the Professional, Scientific, and Technical Services sector.

This page collects what Stock Titan holds for PAND, including price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.

Stock Performance

Chart
$—
-
-
Last updated:
-
Performance 1 year
-
Market Cap
-
Shares outstanding

Latest News

View All
+133.36%

Merck to Acquire Pandion Therapeutics

acquisition
+9.36%

Pandion Therapeutics Presents Preclinical Data Highlighting Potential of Tissue-Tethered PD-1 Agonist to Locally Target Autoimmune Disease at the nPOD 13th Annual Scientific Meeting

clinical trial
-1.50%

Pandion Therapeutics to Present at the 10th Annual SVB Leerink Global Healthcare Conference

conferences
+47.74%

Pandion Therapeutics Announces Positive Top-Line Phase 1a Clinical Data Showing PT101 was Well-Tolerated and Selectively Expanded Regulatory T cells

clinical trial
-0.35%

Pandion Therapeutics Appoints Katina Dorton to its Board of Directors

management
+11.43%

Pandion Therapeutics Reports Third Quarter 2020 Financial Results and Provides Business Update

earnings

Pandion Therapeutics has 10 recent news articles. Of the recent coverage, 4 articles coincided with positive price movement and 6 with negative movement. Key topics include acquisition, clinical trial, conferences, management, earnings. View all PAND news →

SEC Filings

View All

No SEC filings available for PAND.

Financial Highlights

—
Revenue (latest FY)
—
Net Income (latest FY)
—
Diluted EPS (latest FY)
—
Operating Cash Flow
—
Net Profit Margin
—
Oper. Profit Margin

Upcoming Events

Short Interest History

Last 12 Months

Days to Cover History

Last 12 Months

PAND Company Profile & Sector Positioning

Pandion Therapeutics (PAND) operates in the Research and Development in Biotechnology industry within the broader Professional, Scientific, and Technical Services sector and is listed on the NASDAQ.